More Bonds of Euronet Worldwide Inc. Moody’s Daily Credit Risk Score About the Euronet Worldwide Inc.-Bond (XS2001315766) The Euronet Worldwide Inc.-Bond has a maturity date of 5/22/2026 and offers a ...
Performance charts including intraday, historical charts and prices and keydata.
Winston-Salem, N.C., April 22, 2026 (GLOBE NEWSWIRE) -- Truliant Federal Credit Union and Piedmont Advantage Credit Union announced they have signed a definitive agreement to combine, uniting two ...
Acquisition Positions Amneal to Capitalize on $300B+ Global Biologics LOE Opportunity –– Transaction Accelerates Growth Profile and ...
More Bonds of Marathon Petroleum Corp. Moody’s Daily Credit Risk Score About the Marathon Petroleum Corp.-Bond (US56585ABL52) The Marathon Petroleum Corp.-Bond has a maturity date of 3/1/2035 and ...
More Bonds of Ford Credit Canada Co. Moody’s Daily Credit Risk Score About the Ford Credit Canada Co.-Bond (CA34527ACT57) The Ford Credit Canada Co.-Bond has a maturity date of 2/9/2029 and offers a ...
McGurn, who has served as an advisor to Trump Media since December 2024, will succeed current CEO Devin Nunes, and will lead the Company’s strategic initiatives across social media, streaming, and ...
More Bonds of Carnival Corp. Moody’s Daily Credit Risk Score About the Carnival Corp.-Bond (US143658BX94) The Carnival Corp.-Bond has a maturity date of 2/15/2033 and offers a coupon of 6.1250%. The ...
The Royal Bank of Canada-Bond has a maturity date of 5/4/2027 and offers a coupon of 1.4500%. The payment of the coupon will take place 1,0 times per Year on the 04.05.. At the current price of 101.17 ...
Copyright © 2026 Insider Inc and finanzen.net GmbH (Imprint). All rights reserved. Registration on or use of this site constitutes acceptance of our Terms of Service ...
Elevate Payroll : Paylocity administers payroll processes on behalf of clients, helping reduce effort, improve accuracy, and minimize risk. Elevate HR : Paylocity provides ongoing HR operational ...
In the United States, ONS-5010/LYTENAVA™ (bevacizumab-vikg) is investigational. If approved in the United States, ONS-5010/LYTENAVA™, would be the first approved ophthalmic formulation of bevacizumab ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results